Physiology versus evidence-based guidance for critical care practice by unknown
REVIEW Open Access
Physiology versus evidence-based guidance for
critical care practice
Luciano Gattinoni1,2*, Eleonora Carlesso1 and Alessandro Santini2
Abstract
Evidence based medicine is an attempt to optimize the medical decision process through methods primarily based
on evidence coming from meta-analyses, systematic reviews, and randomized controlled trials ("evidence-based
medicine”), rather than on “clinical judgment” alone. The randomized trials are the cornerstones of this process.
However, the randomized trials are just a method to prove or disprove a given hypothesis, which, in turn, derives
from a general observation of the reality (premises or theories). In this paper we will examine some of the most
recent randomized trials performed in Intensive Care, analyzing their premises, hypothesis and outcome. It is quite
evident that when the premises are wrong or too vague the unavoidable consequences will be a negative
outcome. We should pay when designing the trial an equal attention in defining premises and hypothesis that we
pay for the trial conduction.
Introduction
It is not easy to state when and where intensive care
medicine was born. Although continuous assistance, as
provided during the Crimean War by Florence Nightin-
gale, included the basic principles of intensive care,
most people agree that the Copenhagen polio epidemic
represents the starting point of this discipline. Establish-
ing respiratory homeostasis, buying time for recovery
through artificial ventilation, still represents one of the
basic principles on which intensive care is founded.
The substantial difference between intensive care and
other medical disciplines is that the latter aim at correct-
ing and treating specific diseases, while intensive care pri-
marily treats the homeostasis of the whole person. In
general, while most diseases originate in the domain of
molecular biology, the homeostasis is maintained by bulk
flows of gas and blood at appropriate pressures, which
are in the domain of physiology. Therefore it has been
natural that intensive care and physiology since the very
beginning were strictly associated.
In the mid-1980s Alvin Feinstein [1] and David Sackett
et al. [2] translated epidemiological methods into physi-
cian decision-making, in an attempt to optimize the med-
ical decision, based primarily on evidence coming from
meta-analyses, systematic reviews, and randomized con-
trolled trials (“evidence-based medicine”), rather than on
“clinical judgment” alone. Although Sackett et al. expli-
citly stated that this approach necessitates “integrating
individual clinical expertise with the best available exter-
nal clinical evidence from systematic research” [3], in the
following years the systematic research, primarily from
randomized trials, became the only accepted way to
assess the value of a given intervention. This approach
led to the flowering of new professional figures, as “meta-
analysts” and “trialists”, who had the final word on jud-
ging the internal validity (how it is performed) and the
external validity (how it can be generalized) of a given
trial. The results of “good trials”, according to the adher-
ents to the new “religion” of evidence-based medicine,
were incorporated in guidelines and recommendations.
This process appears unquestioned and unstoppable. To
rephrase a famous Bob Dylan line, there are no truths
outside the gates of evidence-based medicine.
The scientific method
Epistemology is a word indicating the philosophy of
science. Over the centuries, scientific reasoning has been
developed according to quite definite pathways. Accord-
ingly we may consider the place of randomized trials,
currently the primary sources of evidence, in the main-
stream of processes that allow the acquiring of knowl-
edge [4]. Briefly, the process in medicine starts with
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empiric observations from which a theory or premise is
developed. As an example, observing that an imbalance
between oxygen supply and oxygen demand may lead to
organ dysfunction, which in turn may be associated with
increased mortality, led to a general theory that tissue
hypoxia is harmful. Physiological reasoning showed that
central venous oxygenation (SvO2) is an indicator of the
balance between oxygen supply and demand. In intensive
care, therefore, an accepted theory/premise is that oxygen
imbalance is harmful and that SvO2 may measure it. The
theories therefore follow an inductive process: from parti-
cular observations it is possible to derive a general state-
ment. Until the 17th century the validity of the theories
had to be found inside the mind, as for Aristotle or Des-
cartes, or founded on God, as in Saint Thomas in the Mid-
dle Age. From the general law, through a logic process, a
deduction was made. This way of reasoning is the struc-
ture of the syllogism: “All men are mortals. Socrates is a
man. Therefore, Socrates is mortal”. What dramatically
changed in the 17th century was the approach to validate
the theories from which hypotheses were generated. The
theory was valid only if verified through an experiment
and described in mathematical language, as for Galileo
and Newton. In the 20th century Popper reasoned that it
is impossible to prove that a given theory is valid; it is only
possible to prove that it is incorrect. This is the basis of
the trial and error approach (disprove a theory and gener-
ate a new one). Note, however, that the deductive process,
through which from a general law a particular hypothesis
is derived, has been unquestioned throughout the centu-
ries. A summary of the steps required to improve our
scientific knowledge is presented in Figure 1.
Premises disproved by trials: the supranormal
hemodynamics example
Randomized trials are one of the possible experiments
which can be used to prove or disprove a given hypothesis
that, in turn, originates from a given theory. If tissue
hypoxia is harmful and SvO2 is one of the forms of its
measurement (inductive reasoning), a possible hypothesis
is that its correction while monitoring/targeting SvO2 may
decrease the organ dysfunction and improve survival
(deductive reasoning). It is worth noting that “the truth”,
which the trial aims to disclose, is implicit in the pre-
mises/theories and that a “negative” trial just indicates that
the premises are incorrect or incomplete.
The tissue hypoxia theory generated a series of trials,
starting with Shoemaker et al. [5] who proposed supra-
normal values of the cardiac index to improve survival.
The implicit theory/premise was that critically ill
patients have a supranormal need for oxygen, implying
that a normal supply of oxygen would not be sufficient
for their needs. Firm physiological support was lacking,
however, as the Shoemaker theory derived simply from
the observation that patients who survived after major
surgery had higher cardiac indexes than the patients
who died. This theory was then translated, without solid
physiological plausibility, to the entire population of
intensive care patients. Two randomized trials failed to
show differences between the patients treated with
supranormal values and normal values [6,7] and this
was the end of targeting supranormal hemodynamic
variables in general intensive care. These two studies
showed that the premises were incomplete/wrong; that
is, there is no necessity for a greater global oxygen sup-
ply in critically ill patients.
In one of these studies [7], however, another arm,
apart from the supranormal arm, was added. In this
group of patients the treatment was directed to reach/
maintain SvO2 at values >70%. Results showed that this
group was indistinguishable from a group in which nor-
mal values of the cardiac index (>2.5 l/minute/m2) were
the aim of treatment, indicating that targeting the
hemodynamic treatment to normal SvO2 or to normal
cardiac index are equivalent strategies. Of note, how-
ever, the SvO2 values recorded in all patients entering
into the study were close to the target of 70%, indicating
that oxygen imbalance, on average, was absent in the
general ICU population studied.
Wrong premises versus wrong conclusions: the
early goal-directed therapy trials example
Ten years later, in a subgroup of critically ill patients with
severe sepsis and septic shock, Rivers et al. [8] presented
a study of early goal-directed therapy (EGDT). The pre-
mises/theories behind the study were that: oxygen imbal-
ance is common in patients with severe sepsis and septic
shock; hypoxemia leads to multiorgan dysfunction and
mortality; and SvO2 is the indicator of the oxygen sup-
ply/demand balance. The hypothesis deduced from these
premises and tested by Rivers et al. was that an early
Figure 1 Steps in the process of scientific knowledge
accumulation. RCT randomized controlled trial.
Gattinoni et al. Critical Care 2015, 19:S7
http://www.ccforum.com/content/19/S3/S7
Page 2 of 5
intervention, aimed at correcting the oxygen supply/
demand imbalance, could improve survival by limiting
organ dysfunction. Actually, the Rivers et al. study
showed an impressive improvement in survival in the
EGDT group. Note that a baseline SvO2 of around 50%
in the patients enrolled clearly indicated the presence of
an oxygen imbalance.
To improve the evidence and to dissipate some con-
cerns about the Rivers et al. study, three other large trials
were organized in the following years: the Protocolised
Management in Sepsis [ProMISe] trial [9], the Australa-
sian Resuscitation in Sepsis Evaluation [ARISE] trial [10]
and the Protocolized Care for Early Septic Shock [Pro-
CESS] trial [11]. Despite some differences in trial design,
the core of these experiments was the same: to test
whether EGDT, as designed by Rivers et al., is of real
benefit in patients with severe sepsis or septic shock. All
trials tested the same premises/theories that Rivers et al.
tested but, in contrast to their results, no outcome bene-
fits were found in the treated groups. The conclusions
were that EGDT in sepsis and septic shock does not
work. What these trials actually proved was simply that
one or more of the theories/premises on which the trials
were based was false. In observing the population
enrolled in these trials, it is quite obvious that the first
premise ("oxygen imbalance is common in patients with
severe sepsis and septic shock”) was false. Actually the
average SvO2 at baseline was ≥70% in all the three trials,
compared with 50% in the Rivers et al. study. Therefore,
in our opinion, these trials simply showed that the oxy-
gen imbalance may not be common in the sepsis/septic
shock population as currently defined. Not surprisingly,
any intervention to correct a nonexistent “oxygen imbal-
ance” is futile. Consequently, to say that SvO2 measure-
ment is useless, as possibly suggested by these trials’
results, is nonsense. Physiology continues to tell us that
SvO2 is an indicator of the oxygen supply/demand bal-
ance and that, when tissue hypoxia is really present - as
in the Rivers et al. study [8] and not in the aforemen-
tioned recent trials [9-11] - the correcting intervention
makes sense.
This is one example of how randomized trials may be
misleading. There are many published trials in which
the premises are so vague or biologically implausible
that the so-called negative results are an unavoidable
consequence.
Strong premises and integration of physiology
and evidence: the low tidal volume in acute
respiratory distress syndrome example
Let us now examine what is probably the most impor-
tant randomized clinical trial in intensive care: the lower
versus higher tidal volume treatment in acute respira-
tory distress syndrome (ARDS) [12]. The premises of
the trial were that nonphysiological stresses and strains
applied by mechanical ventilation may produce further
injury to the lung, which leads to an increase in mortal-
ity. Following experts in the field, lower tidal volume
was set at 6 ml/kg ideal body weight (IBW) and higher
tidal volume at 12 ml/kg IBW. Note that the IBW was
kept as a surrogate of the normal lung dimensions
expected in each individual. The results were straight-
forward: 6 ml/kg IBW ventilation provided clear-cut
outcome advantages. From a different point of view,
12 ml/kg IBW provided clear-cut disadvantages. It must
be noted, however, that previous studies comparing dif-
ferent values of tidal volumes such as ≅7 ml/kg vs.
≅10 ml/kg [13-15] did not find any difference. In addi-
tion, in some patients in which 6 ml/kg tidal volume
induces hypoventilation, there is high possibility of reab-
sorption atelectasis, further hypoxemia, and right ventri-
cular dysfunction. Therefore while the “evidence” tells
us that 12 ml/kg is more dangerous than 6 ml/kg, only
the physiology may tell us whether 6 ml/kg is adequate
or “too high” [16], in which case extracorporeal respira-
tory support is indicated, or “too low” [17], in which
case higher tidal volume may be required. Only the phy-
siology-oriented approach may tell us to monitor and
treat a patient according to his/her actual needs. In a
sense, this is what was suggested by Sackett et al.: inte-
grating clinical judgment (physiological based) with evi-
dence (higher strain is in generally worse than lower
strain).
Strong physiological rationale without evidence:
the positive end-expiratory pressure in ARDS
example
The best example of how physiology overcomes the “evi-
dence” is the setting of positive end-expiratory pressure
(PEEP). PEEP at an undefined pressure level being of
benefit in ARDS derives from a series of experimental
and clinical studies. In normal lungs, as sustained by
Webb and Tierney [18] in their famous experiment, the
use of PEEP may prevent or sharply decrease the lung
edema induced by “lethal tidal volume”. These observa-
tions were confirmed by a long series of experiments
which showed the “protective effect” of PEEP, particularly
(or exclusively) if associated with a coincident lowering of
tidal volume [19,20]. The clinical use of PEEP dates back
to 1938, when Barach et al. [21] published the effects of
PEEP on normal man and in patients with pulmonary
edema. After Gregory et al.’s [22] observation in infants
and the description of ARDS by Ashbaugh et al. [23], the
use of PEEP in adults became widespread. Since then,
PEEP has always been used in ARDS, aiming to improve
oxygenation in the early years and to reduce lung injury
by increasing lung homogeneity and avoiding intratidal
collapse in the last decades [24]. Although the use of
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PEEP is unquestioned, its correct setting lays still in the
darkness. If PEEP worked in ARDS as in experimental
animals, there is no doubt that clinical results would be
excellent. Unfortunately, when randomized controlled
trials were performed, no clear-cut difference between
higher and lower PEEP was observed. In fact, three stu-
dies in which PEEP was selected according to different
methods, but ended up with a higher PEEP around 13-15
cmH2O and a lower PEEP around 7-9 cmH2O, showed
similar mortality in the two arms [25-27]. These studies
enrolled ARDS patients whose severity spanned from
mild to severe according to the Berlin classification [28].
Let us now examine the premises and theories for which
higher or lower PEEP should lead to differences in mortal-
ity: in ARDS, mechanical ventilation may be injurious as
potentially producing intratidal collapse and decollapse,
which is harmful to the lung structure; intratidal collapse
and decollapse is usual in most ARDS patients; lower
PEEP, although providing viable oxygenation, does not
prevent injurious intratidal collapse and decollapse; and
higher PEEP, although overdistending some lung regions
and interfering more with hemodynamics, prevents injur-
ious intratidal collapse and decollapse.
The hypothesis generated from these premises, which
derive from physiological observations, is that in most
ARDS patients the potential damages of higher PEEP
are lower than the potential damages of intratidal col-
lapse and decollapse, leading to less ventilator-induced
lung injury and better outcome.
All trials comparing higher versus lower PEEP were
“negative”, indicating that the premises were incomplete
or wrong. Physiology and commonsense tell us that for
PEEP to work some recruitable collapse must be pre-
sent. It must be noted that mild ARDS and a consistent
fraction of moderate ARDS do not present collapsed
regions which are recruitable within the range of con-
ventional tidal volumes [29]; that is, there are no pre-
requisites for PEEP to work.. Physiology tells us also
that the more dependent the collapsed region, the
higher the pressure required to keep that region open.
Knowing this, it becomes evident that what the afore-
mentioned randomized trials told us was simply that
the second premise ("intratidal collapse and decollapse
is usual in most of ARDS patients”) is not satisfied.
Therefore, to test whether the benefits of higher PEEP
overcome its possible harms, compared with lower
PEEP, patients in the trial should satisfy the second pre-
mise; that is, they must present collapsed/recruitable
lung units, which are more frequent in severe ARDS.
Actually some meta-analyses already suggest that the
more severe the patient, the better the potential for a
beneficial effect from higher PEEP [30]. A recent pro-
spective trial that targeted such patients corroborates
this interpretation [31].
Conclusions
As currently practiced, evidence-based medicine relies
on randomized controlled trials, from which reviews
and meta-analyses primarily derive. It is evident that if
the premises of the trials are incomplete, wrong, or too
vague, the results of the trial will be negative. It is
impressive to see the disproportion between the atten-
tion paid to the design of a trial compared with that
spent analyzing the validity of the premises and the
derived hypotheses. Negative results are often attributed
to the heterogeneity of the population. This just derives
from the lack of a clear definition of the problem that
the trial is designed to solve. Severe sepsis/septic shock
is by definition heterogeneous, but if we concentrated
on the oxygen balance for patient selection then the het-
erogeneity problem would be in part overcome. ARDS is
by definition heterogeneous, but if we concentrate on
the amount of recruitability to enroll the patients in a
PEEP trial then the heterogeneity would in part disap-
pear. In conclusion, physiology helps to design premises
and theories; without strong premises and theories,
whatever the trial will prove is, in the best case, useless
or, if misinterpreted, dangerous.
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